The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
Cystinosis is an autosomal recessive metabolic disease that belongs to the family of lysosomal storage disorders. It is caused by a defect in the lysosomal cystine transporter, cystinosin, which results in an accumulation of cystine in all organs. Despite the ubiquitous expression of cystinosin, a renal Fanconi syndrome is often the first manifestation of cystinosis, usually presenting within the first year of life and characterized by the early and severe dysfunction of proximal tubule cells, highlighting the unique vulnerability of this cell type. The current therapy for cystinosis, cysteamine, facilitates lysosomal cystine clearance and greatly delays progression to kidney failure but is unable to correct the Fanconi syndrome. This Review summarizes decades of studies that have fostered a better understanding of the pathogenesis of the renal Fanconi syndrome associated with cystinosis. These studies have unraveled some of the early molecular changes that occur before the onset of tubular atrophy and identified a role for cystinosin beyond cystine transport, in endolysosomal trafficking and proteolysis, lysosomal clearance, autophagy and the regulation of energy balance. These studies have also led to the identification of new potential therapeutic targets and here, we outline the potential role of stem cell therapy for cystinosis and provide insights into the mechanism of haematopoietic stem cell-mediated kidney protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2012) · The Scientific World JOURNAL · doi:10.1100/tswj · Cited by 2,595
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543 · cited 1×
“Another approach is to enhance TFEB levels, as TFEB triggers lysosome biogenesis and promotes the clearance of accumulated protein aggregates 169 , in models of Huntington 170 and Parkinson disease 171 .”
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464 · cited 1×
“Upon stimulation by amino acids, the small GTPases Ras-related GTP-binding proteins (Rag) and the pen-tameric Ragulator complex recruit cytosolic mTORC1 to the lysosomal membrane, close to its activator, Rheb GTPase 137,138 .”
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207056 · Cited by 1,673 · cited 1×
“The vacuolar ATPase (v-ATPase) proton pump is necessary for mTORC1 activation by amino acids, by engaging in amino acid-sensitive interactions with the Rag–Ragulator complex 137,141 .”
Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Biffi, A., Montini, E., Lorioli, L., Cesani, M., Fumagalli, F., Plati, T., Baldoli, C., Martino, S., Calabria, A., Canale, S., et al. (2013) · Science · doi:10.1126/science.1233158 · Cited by 1,180 · cited 1×
“…infection, β-thalassemia, immunodeficiency diseases such as severe combined or adenosine deaminase immuno-deficiency and metabolic diseases such as adrenoleuko-dystrophy and metachromatic leukodystrophy; no major adverse events have been reported so far, but extreme care remains necessary 191–195 .”
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918 · cited 3×
“The vacuolar ATPase (v-ATPase) proton pump is necessary for mTORC1 activation by amino acids, by engaging in amino acid-sensitive interactions with the Rag–Ragulator complex 137,141 .”
Chaperone-mediated autophagy: a unique way to enter the lysosome world
Kaushik, S., & Cuervo, A. M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.05.006 · Cited by 850
Pathogenic Lysosomal Depletion in Parkinson's Disease
Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1920-10.2010 · Cited by 825 · cited 1×
“Another approach is to enhance TFEB levels, as TFEB triggers lysosome biogenesis and promotes the clearance of accumulated protein aggregates 169 , in models of Huntington 170 and Parkinson disease 171 .”
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Medina, D. L., Fraldi, A., Bouche, V., Annunziata, F., Mansueto, G., Spampanato, C., Puri, C., Pignata, A., Martina, J. A., Sardiello, M., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.016 · Cited by 716 · cited 1×
“Another approach is to enhance TFEB levels, as TFEB triggers lysosome biogenesis and promotes the clearance of accumulated protein aggregates 169 , in models of Huntington 170 and Parkinson disease 171 .”
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Platt, F. M., Boland, B., & van der Spoel, A. C. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208152 · Cited by 689
Regulation of mTORC1 and its impact on gene expression at a glance
Laplante, M., & Sabatini, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125773 · Cited by 667 · cited 1×
“Conversely, starvation (amino acid deprivation) inactivates mTORC1, thereby triggering mobilization of nutrient reserves by activating autophagy 139,140 .”
A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“depletion activates AMPK, which inhibits mTORC1 thus activates autophagy (13).”
Self-citationActivation of Chaperone-mediated Autophagy during Oxidative Stress
Kiffin, R., Christian, C., Knecht, E., & Cuervo, A. M. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-06-0477 · Cited by 612 · cited 1×
“Importantly, CMA is activated during oxidative stress to facilitate the clearance of irreversibly modified molecules 148 ; therefore, impaired CMA in cystinosis could increase cell sensitivity to oxidative stress.”
Futter, C. E., Pearse, A., Hewlett, L. J., & Hopkins, C. R. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.6.1011 · Cited by 530 · cited 2×
“The combination of these effects should block interlysosomal exchange, and thereby arrest randomization of endocytic load between lysosomes, thus favour their conversion into residual bodies 89,90 .”
Consequences of the selective blockage of chaperone-mediated autophagy
Massey, A. C., Kaushik, S., Sovak, G., Kiffin, R., & Cuervo, A. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507436103 · Cited by 529 · cited 1×
“The various autophagy defects observed in cys-tinosis are probably interconnected, as impairment of CMA impairment might induce compensatory activation of other autophagic pathways 147,149 .”
Önfelt, B., Nedvetzki, S., Benninger, R. K. P., Purbhoo, M. A., Sowinski, S., Hume, A. N., Seabra, M. C., Neil, M. A. A., French, P. M. W., & Davis, D. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8476 · Cited by 492 · cited 1×
“These TNTs support long-distance intercellular communication, vesicular trafficking and pathogen spreading 181–183 .”
Chevalier, R. L. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00164.2016 · Cited by 483
Smith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Amino acids and mTORC1: from lysosomes to disease
Efeyan, A., Zoncu, R., & Sabatini, D. M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.007 · Cited by 436 · cited 2×
“In turn, impaired proteolysis could affect lysosomal amino acid sensors , such as mTORC1, thereby affecting lysosomal signalling 132 (FIG.”
A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation
Li, X., Rydzewski, N., Hider, A., Zhang, X., Yang, J., Wang, W., Gao, Q., Cheng, X., & Xu, H. (2016) · Nature Cell Biology · doi:10.1038/ncb3324 · Cited by 387 · cited 2×
“…numbers of microtubular contacts via their cytoskeletal motor protein, dynein, and since the microtubular network is most dense around centrioles 127 ; second, through altered regulation of lysosomal calcium release that controls lysosomal dynamics 127 , although no change in the total level of…”
Elmonem, M. A., Veys, K. R. P., Soliman, N. A., Dyck, M. V., van den Heuvel, L. P., & Levtchenko, E. N. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0426-y · Cited by 352 · cited 1×
“…higher values of free cystine do not necessarily imply the formation of cystine crystals, since up to 20 nmol of half-cystine per mg of protein 88 has been recorded in short-lived cystinotic neutrophils (which are assessed to monitor the efficiency of cysteamine therapy), without evidence of…”
Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.
Thoene, J. G., Oshima, R. G., Crawhall, J. C., Olson, D. L., & Schneider, J. A. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108448 · Cited by 336 · cited 2×
“…also causes rachitism with bone deformities and fragility 40 , which is attributed to massive urinary phosphate loss, defective conversion of 25-hydroxyvitamin D into active calcitriol in the kidney and deposition of cystine in bone, although the exact pathophysiology is not fully…”
Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporter
Kalatzis, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5940 · Cited by 331 · cited 3×
“Cystine is now directly measured as cystine using a mass spectrometer but the values are still reported as half-cystine per mg of protein. for cystine at acidic pH 15 , is much higher than that of other lysosomal amino-acid transporters for their substrates.”
InfluentialChristensen, E. I., Devuyst, O., Dom, G., Nielsen, R., Van Der Smissen, P., Verroust, P., Leruth, M., Guggino, W. B., & Courtoy, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432873100 · Cited by 329 · cited 2×
“…decreased expression of the endocytic receptors megalin and cubilin in PTCs 91,122 , impaired megalin recycling has been reported in cystinotic cells 123 , as in two other hereditary diseases associated with renal Fanconi syndrome: Dent disease 124 and Lowe oculocerebrorenal (OCRL) syndrome 125 .”
Self-citationLeinekugel, P., Michel, S., Conzelmann, E., & Sandhoff, K. (1992) · Human Genetics · doi:10.1007/bf00219337 · Cited by 327
McNeill, A., Magalhaes, J., Shen, C., Chau, K.-Y., Hughes, D., Mehta, A., Foltynie, T., Cooper, J. M., Abramov, A. Y., Gegg, M., et al. (2014) · Brain · doi:10.1093/brain/awu020 · Cited by 321
Cubilin Is Essential for Albumin Reabsorption in the Renal Proximal Tubule
Amsellem, S., Gburek, J., Hamard, G., Nielsen, R., Willnow, T. E., Devuyst, O., Nexo, E., Verroust, P. J., Christensen, E. I., & Kozyraki, R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050492 · Cited by 314 · cited 1×
“Upon selective genetic abrogation of receptor-mediated endocytosis, mice excrete on average roughly 25 μg of albumin per day 85 , indicating that this amount is normally reab-sorbed daily via the megalin–cubilin pathway and transferred to lysosomes, corresponding to ~12 nmol of half-cystine…”
CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney
Soos, T. J., Sims, T. N., Barisoni, L., Lin, K., Littman, D. R., Dustin, M. L., & Nelson, P. J. (2006) · Kidney International · doi:10.1038/sj.ki.5001567 · Cited by 310 · cited 1×
“In this context, resident dendrite cells are known to closely surround tubules and to generate membrane extensions in the healthy kidney, suggesting a role as sensors of the microenvironment 190 .”
Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy
Gahl, W. A., Balog, J. Z., & Kleta, R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00006 · Cited by 276 · cited 2×
“Although early administration of cysteamine therapy delays the progression of cystinosis complications including ESRD 8,10,26,27 , it has no effect on established renal Fanconi syndrome.”
Estimating prevalence in single-gene kidney diseases progressing to renal failure
Levy, M., & Feingold, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00250.x · Cited by 239 · cited 1×
“Cystinosis is a rare, autosomal-recessive, monogenic disorder with a general incidence of 1:100,000–1:200,000 live births 50 .”
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults
Brodin-Sartorius, A., Tête, M.-J., Niaudet, P., Antignac, C., Guest, G., Ottolenghi, C., Charbit, M., Moyse, D., Legendre, C., Lesavre, P., et al. (2012) · Kidney International · doi:10.1038/ki.2011.277 · Cited by 235 · cited 3×
“The shortage of free AAs (7) inhibits mTORC1 (8), which activates”
InfluentialNephropathic cystinosis: an international consensus document
Emma, F., Nesterova, G., Langman, C., Labbe, A., Cherqui, S., Goodyer, P., Janssen, M. C., Greco, M., Topaloglu, R., Elenberg, E., et al. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu090 · Cited by 224
Self-citationChemical modulation of chaperone-mediated autophagy by retinoic acid derivatives
Anguiano, J., Garner, T. P., Mahalingam, M., Das, B. C., Gavathiotis, E., & Cuervo, A. M. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1230 · Cited by 222 · cited 9×
“These autophagosomes supported fully functional macroautophagic fluxes 134 , but cells demonstrated impairment of chaperone-mediated autophagy (CMA) 134 (FIG.”
InfluentialRoles of mTOR complexes in the kidney: implications for renal disease and transplantation
Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B., & Thomson, A. W. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.108 · Cited by 208
Vicinanza, M., Di Campli, A., Polishchuk, E., Santoro, M., Di Tullio, G., Godi, A., Levtchenko, E., De Leo, M. G., Polishchuk, R., Sandoval, L., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.354 · Cited by 196 · cited 1×
“…decreased expression of the endocytic receptors megalin and cubilin in PTCs 91,122 , impaired megalin recycling has been reported in cystinotic cells 123 , as in two other hereditary diseases associated with renal Fanconi syndrome: Dent disease 124 and Lowe oculocerebrorenal (OCRL) syndrome 125 .”
Intracellular cysteine and glutathione delivery systems.
Meister, A., Anderson, M. E., & Hwang, O. (1986) · Journal of the American College of Nutrition · doi:10.1080/07315724.1986.10720121 · Cited by 192
Jézégou, A., Llinares, E., Anne, C., Kieffer-Jaquinod, S., O’Regan, S., Aupetit, J., Chabli, A., Sagné, C., Debacker, C., Chadefaux-Vekemans, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211198109 · Cited by 182 · cited 2×
“…when protonated, as occurs in the acidic lysosomal lumen 75 , in contrast to micromolar ranges for the lysosomal amino acid transporter PQ loop repeat containing protein-2 (PQLC2; 3 mM for arginine and even higher for lysine 77 ), and peptide/histidine transporter-2 (PHT2; 5 mM for histidine 78 ).”
Piotrowska, E., Jakóbkiewicz-Banecka, J., Barańska, S., Tylki-Szymańska, A., Czartoryska, B., Węgrzyn, A., & Węgrzyn, G. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201623 · Cited by 175 · cited 1×
“…nuclear translocation and activation of TFEB-dependent lysosome biogenesis by genistein 172 , has been reported to decrease lysosomal storage of glycosaminoglycans due to mucopolysaccharidosis in vitro 173 and has been validated in a pilot clinical trial resulting in cognition improvement 174 .”
Multifaceted Roles of Tunneling Nanotubes in Intercellular Communication
Marzo, L., Gousset, K., & Zurzolo, C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00072 · Cited by 169
Park, M., Helip-Wooley, A., & Thoene, J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000036867.49866.59 · Cited by 167 · cited 1×
“Cystinotic fibroblasts and PTCs are particularly vulnerable to apoptosis 102,103 .”
Pisoni, R. L., Acker, T. L., Lisowski, K. M., Lemons, R. M., & Thoene, J. G. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.2.327 · Cited by 162
Pharmaceutical approval update.
Goldenberg, M. M. (2008) · Europe PMC (PubMed Central) · Cited by 157
Lysosome Transport as a Function of Lysosome Diameter
Bandyopadhyay, D., Cyphersmith, A., Zapata, J. A., Kim, Y. J., & Payne, C. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086847 · Cited by 153
Attard, M., Jean, G., Forestier, L., Cherqui, S., Hoff, W. V., Broyer, M., Antignac, C., & Town, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2507 · Cited by 146
Self-citationMitochondrial Autophagy Promotes Cellular Injury in Nephropathic Cystinosis
Sansanwal, P., Yen, B., Gahl, W. A., Ma, Y., Ying, L., Wong, L.-J. C., & Sarwal, M. M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040383 · Cited by 145 · cited 1×
“One major function is in the control of autophagy, and increased numbers of autophagosomes, especially enclosing mitochondria, have been reported in various cystinotic cell lines as well as in liver and kidney from Ctns -knockout mice 134,135 .”
Hereditary Disorders in Saguenay-Lac-St-Jean (Quebec, Canada)
Braekeleer, M. D. (1991) · Human Heredity · doi:10.1159/000153992 · Cited by 141
Therapy for lysosomal storage disorders
Beck, M. (2010) · IUBMB Life · doi:10.1002/iub.284 · Cited by 139 · cited 1×
“Indeed, cross-correction , that is, the transfer of a functional protein from wild-type cells to deficient cells, has been well demonstrated in several lysosomal storage disorders caused by defective soluble hydrolases, after bone marrow transplantation or by recombinant enzyme infusion 178 .”
Kalatzis, V. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh152 · Cited by 137 · cited 2×
“For example, two missense mutations in CTNS — Lys280Arg and Asn323Lys — found in patients with juvenile cystinosis, result in undetectable levels of cystine transport, yet these mutated forms of cystinosin still localize at lysosomes 81 .”
Cherqui, S., Kalatzis, V., Trugnan, G., & Antignac, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010562200 · Cited by 135 · cited 3×
“In particular, the role(s) of the second PQ-loop in cystinosin, which in addition to lyso somal targeting carries a cystine–proton binding site and includes the interaction site with mTORC1 14,75,142 , deserves further study.”
Self-citationNaphade, S., Sharma, J., Gaide Chevronnay, H. P., Shook, M. A., Yeagy, B. A., Rocca, C. J., Ur, S. N., Lau, A. J., Courtoy, P. J., & Cherqui, S. (2015) · Stem Cells · doi:10.1002/stem.1835 · Cited by 130 · cited 4×
“However, bone marrow-derived macrophages engrafted in cystinotic kidneys generate nanotubular extensions that readily cross the tubular basement membrane and deliver cystinosin into diseased PTCs 179 (FIG.”
InfluentialSelf-citationZONAB Promotes Proliferation and Represses Differentiation of Proximal Tubule Epithelial Cells
Lima, W. R., Parreira, K. S., Devuyst, O., Caplanusi, A., N’Kuli, F., Marien, B., Smissen, P. V. D., Alves, P. M. S., Verroust, P. J., Christensen, E. I., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070698 · Cited by 129 · cited 1×
“…from Ctns -knockout mice have demonstrated loss of megalin to be associated with the nuclear translocation of ZO-1-associated nucleic acid binding protein (ZONAB) 122 , a transcription factor that promotes cell proliferation and downregulates megalin and cubulin expression as direct targets 153 .”
Self-citationMoskot, M., Montefusco, S., Jakóbkiewicz-Banecka, J., Mozolewski, P., Węgrzyn, A., Di Bernardo, D., Węgrzyn, G., Medina, D. L., Ballabio, A., & Gabig-Cimińska, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555300 · Cited by 129 · cited 1×
“Induction of TFEB expression, nuclear translocation and activation of TFEB-dependent lysosome biogenesis by genistein 172 , has been reported to decrease lysosomal storage of glycosaminoglycans due to mucopolysaccharidosis in vitro 173 and has been validated in a pilot clinical trial resulting in…”
Lentiviral Hematopoietic Cell Gene Therapy for X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Bougnères, P., Schmidt, M., Von Kalle, C., Fischer, A., Cavazzana-Calvo, M., & Aubourg, P. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-386509-0.00010-7 · Cited by 123
Kyttälä, A., Ihrke, G., Vesa, J., Schell, M. J., & Luzio, J. P. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0120 · Cited by 119 · cited 1×
“Paired lysosomal sorting motives are thought to ensure robust targeting of the protein to the lysosome, and are present in other lysosomal membrane proteins, such as battenin, which is involved in the neurodegenerative disorder Batten disease 73 .”
Exome Sequencing Reveals Cubilin Mutation as a Single-Gene Cause of Proteinuria
Övünç, B., Otto, E. A., Vega-Warner, V., Saisawat, P., Ashraf, S., Ramaswami, G., Fathy, H., Schoeb, D. S., Chernin, G., Lyons, R. H., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040337 · Cited by 116 · cited 1×
“Similar calculations can be extended to humans, on the basis of high levels of proteinuria observed in patients with homozygous deletion of the gene that encodes cubilin 86 .”
Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells
Rega, L. R., Polishchuk, E., Montefusco, S., Napolitano, G., Tozzi, G., Zhang, J., Bellomo, F., Taranta, A., Pastore, A., Polishchuk, R., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.045 · Cited by 115 · cited 16×
“Moreover, cysteamine drug, another source of cytoplasmic cysteine, does not prevent the renal Fanconi syndrome, suggesting the contribution of factors other than cysteine deficiency to this phenotype. acid supply), to regulate autophagy and cell differentiation through various pathways including through transcription…”
InfluentialPiotrowska, E., Jakóbkiewicz‐Banecka, J., Tylki‐Szymańska, A., Liberek, A., Maryniak, A., Malinowska, M., Czartoryska, B., Puk, E., Kłoska, A., Liberek, T., et al. (2008) · Current Therapeutic Research · doi:10.1016/j.curtheres.2008.04.002 · Cited by 110 · cited 1×
“…nuclear translocation and activation of TFEB-dependent lysosome biogenesis by genistein 172 , has been reported to decrease lysosomal storage of glycosaminoglycans due to mucopolysaccharidosis in vitro 173 and has been validated in a pilot clinical trial resulting in cognition improvement 174 .”
Wilmer, M. J. G., Kluijtmans, L. A. J., van der Velden, T. J., Willems, P. H. G. M., Scheffer, P. G., Masereeuw, R., Monnens, L. A. H., van den Heuvel, L. P., & Levtchenko, E. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.010 · Cited by 106 · cited 2×
“In addition, cysteam-ine releases equimolar amounts of cysteine from the lysosomes into the cytosol and cysteamine is also itself a potent antioxidant, shown to increase intracellular levels of GSH 119–121 .”
Swallowing Dysfunction in 101 Patients with Nephropathic Cystinosis
Sonies, B. C., Almajid, P., Kleta, R., Bernardini, I. M., & Gahl, W. A. (2005) · Medicine · doi:10.1097/01.md.0000164204.00159.d4 · Cited by 106
Protein composition and biomechanical properties of in vivo-derived basement membranes
Halfter, W. M., Candiello, J., Hu, H., Zhang, P., Schreiber, E. M., & Balasubramani, M. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.22479 · Cited by 101
Andrzejewska, Z., Névo, N., Thomas, L., Chhuon, C., Bailleux, A., Chauvet, V., Courtoy, P. J., Chol, M., Guerrera, I. C., & Antignac, C. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090937 · Cited by 100 · cited 2×
“Importantly, however, genistein has multiple effects, including activation of AMPK 175 , which as mentioned earlier is activated in primary rabbit PTCs with cystinosis knockdown 101 , and inhibition of mTOR signalling 175 , which is already reduced in cystinotic PTCs 157 .”
Self-citationNapolitano, G., Johnson, J. L., He, J., Rocca, C. J., Monfregola, J., Pestonjamasp, K., Cherqui, S., & Catz, S. D. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404223 · Cited by 97 · cited 5×
“These autophagosomes supported fully functional macroautophagic fluxes 134 , but cells demonstrated impairment of chaperone-mediated autophagy (CMA) 134 (FIG.”
InfluentialSelf-citationInflammasome Activation by Cystine Crystals
Prencipe, G., Caiello, I., Cherqui, S., Whisenant, T. C., Petrini, S., Emma, F., & Benedetti, F. D. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060653 · Cited by 94 · cited 1×
“Crystals might, however, be crucial in driving the progression of renal disease at later stages, for example, by activating the inflammasome to trigger inflammation and fibrosis 93 .”
Self-citationRaggi, C. C., Luciani, A., Névo, N., Antignac, C., Terryn, S., & Devuyst, O. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt617 · Cited by 93 · cited 7×
“Second, cystinotic lysosomes become enlarged and cluster to the perinuclear region of cells, reflecting impaired lysosome motility and indicating reduced accessibility to endocytic and autophagic loads 122,123 .”
InfluentialHematopoietic Stem Cell Gene Therapy for the Multisystemic Lysosomal Storage Disorder Cystinosis
Harrison, F., Yeagy, B. A., Rocca, C. J., Kohn, D. B., Salomon, D. R., & Cherqui, S. (2012) · Molecular Therapy · doi:10.1038/mt.2012.214 · Cited by 93 · cited 3×
“Preclinical studies using such an approach have been completed in Ctns -knockout mice and showed evidence of efficacy 176 .”
Self-citationAnikster, Y., Lucero-Obusan, C. A., Touchman, J. W., Huizing, M., McDowell, G. A., Shotelersuk, V., Green, E. D., & Gahl, W. A. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2790 · Cited by 91 · cited 1×
“A higher local incidence has been reported in French Brittany (1:26,000 live births) 51,52 and Saguenay–Québec (1:62,500 live births) 53 , due to distinct founder mutations in CTNS (c.898–900 + 24del27 13,27,57 but almost never occurs in other families 58–61 .”
Fanin, M., Nascimbeni, A. C., Fulizio, L., Spinazzi, M., Melacini, P., & Angelini, C. I. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050646 · Cited by 88 · cited 1×
“Moreover, isolated autophagy deficits observed in Danon disease, a lysosomal storage disorder caused by mutations in LAMP2 (REFS 150,151) , do not lead to a renal phenotype 150,152 , implying that this defect cannot be the primary reason for the Fanconi syndrome associated with cystinosis.”
Structural basis for the facilitative diffusion mechanism by SemiSWEET transporter
Lee, Y., Nishizawa, T., Yamashita, K., Ishitani, R., & Nureki, O. (2015) · Nature Communications · doi:10.1038/ncomms7112 · Cited by 87 · cited 1×
“The cystine and proton-binding site in cystinosin belongs to this second PQ-loop 75 , as seen in other PQ-loop proteins such as the SWEET sugar transporters 76 .”
Time Course of Pathogenic and Adaptation Mechanisms in Cystinotic Mouse Kidneys
Chevronnay, H. P. G., Janssens, V., Smissen, P. V. D., N’Kuli, F., Névo, N., Guiot, Y., Levtchenko, E. N., Marbaix, É., Pierreux, C. E., Cherqui, S., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060598 · Cited by 82
Self-citationCysteamine Modulates Oxidative Stress and Blocks Myofibroblast Activity in CKD
Okamura, D. M., Bahrami, N. M., Ren, S., Pasichnyk, K., Williams, J. M., Gangoiti, J. A., López-Guisa, J. M., Yamaguchi, I., Barshop, B. A., Duffield, J. S., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012090962 · Cited by 82
Park, M. A., Pejović, V., Kerisit, K. G., Junius, S., & Thoene, J. G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050474 · Cited by 80 · cited 1×
“Cystinotic fibroblasts and PTCs are particularly vulnerable to apoptosis 102,103 .”
Iglesias, D. M., El-Kares, R., Taranta, A., Bellomo, F., Emma, F., Besouw, M., Levtchenko, E., Toelen, J., van den Heuvel, L., Chu, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042840 · Cited by 79 · cited 1×
“Cystinosin-containing microvesicles and/or exosomes shed by cystinosin-expressing cells have been suggested as potential vehicles to decrease cystine in cystinotic cells 79,180 .”
Disulphide reduction in lysosomes. The role of cysteine
Lloyd, J. B. (1986) · Biochemical Journal · doi:10.1042/bj2370271 · Cited by 75
Genistein-induced LKB1–AMPK activation inhibits senescence of VSMC through autophagy induction
Lee, K. Y., Kim, J., & Choi, H. C. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.02.007 · Cited by 71 · cited 4×
“Importantly, however, genistein has multiple effects, including activation of AMPK 175 , which as mentioned earlier is activated in primary rabbit PTCs with cystinosis knockdown 101 , and inhibition of mTOR signalling 175 , which is already reduced in cystinotic PTCs 157 .”
InfluentialOptimized methods for imaging membrane nanotubes between T cells and trafficking of HIV-1
Sowinski, S., Alakoskela, J.-M. I., Jolly, C. L., & Davis, D. M. (2010) · Methods · doi:10.1016/j.ymeth.2010.04.002 · Cited by 70 · cited 1×
“These TNTs support long-distance intercellular communication, vesicular trafficking and pathogen spreading 181–183 .”
Frey, I. M., Rubio‐Aliaga, I., Siewert, A., Sailer, D., Drobyshev, A., Beckers, J., de Angelis, M. H., Aubert, J., Bar‐Hen, A., Fiehn, O., et al. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00193.2006 · Cited by 70
Altered status of glutathione and its metabolites in cystinotic cells
Levtchenko, E. N., de Graaf-Hess, A., Wilmer, M. J. G., van den Heuvel, L. P., Monnens, L. A. H., & Blom, H. J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh932 · Cited by 70 · cited 1×
“Further studies demonstrated altered glutathione metabolism in skin fibroblasts, polymorphonuclear cells, and cultured PTCs from patients with cystinosis 107,108 .”
V-ATPase/mTOR Signaling Regulates Megalin-Mediated Apical Endocytosis
Gleixner, E. M., Canaud, G., Hermle, T. F., Guida, M. C., Kretz, O., Helmstädter, M., Huber, T. B., Eimer, S., Terzi, F., & Simons, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.035 · Cited by 66 · cited 1×
“…v-ATPase–mTOR activation controls the expression of megalin and thereby regulates apical protein uptake in Drosophila epithelial cells and mouse PTCs 144 , these data provide a possible explanation for the decreased megalin expression in cystinotic kidney, as discussed in further detail below.”
Kidney preservation by bone marrow cell transplantation in hereditary nephropathy
Yeagy, B. A., Harrison, F., Gübler, M.-C., Koziol, J. A., Salomon, D. R., & Cherqui, S. (2011) · Kidney International · doi:10.1038/ki.2010.537 · Cited by 66 · cited 3×
“In addition, heavy inflammatory cell infiltrates can be observed in the renal interstitium 21,23 .”
Self-citationJohnson, J. L., Napolitano, G., Monfregola, J., Rocca, C. J., Cherqui, S., & Catz, S. D. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00417-13 · Cited by 65 · cited 2×
“…calcium store has been detected in cultured cystinotic cells 128 ; and third, through downregulation of Rab–GTPase(s) that normally catalyse lyso somal trafficking, such as Rab27a, which is specifically expressed in PTCs and is downregulated in PTCs from mice and humans with cystinosis 129 .”
Self-citationSaudek, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030876 · Cited by 64 · cited 1×
“The YFPQA sequence comprises part of a ‘PQ-loop’ motif, a defining feature of the PQ-loop family proteins, which are seven transmembrane helices with a duplicated region containing a well-conserved PQ-dipeptide motif 74 .”
Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cells
Laube, G. F., Shah, V., Stewart, V. C., Hargreaves, I. P., Haq, M. R., Heales, S., & Hoff, W. V. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0005-x · Cited by 64 · cited 1×
“Interestingly, one study reported that PTCs extracted from the urine of patients with cystinosis had decreased basal glutathione levels, combined with lower ATP levels and a higher apoptosis rate 111 , suggesting that these defects could be linked.”
Altered mTOR signalling in nephropathic cystinosis
Ivanova, E. A., van den Heuvel, L. P., Elmonem, M. A., SMEDT, H. D., Missiaen, L., Pastore, A., Mekahli, D., Bultynck, G., & Levtchenko, E. N. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9919-z · Cited by 63 · cited 1×
“Impairment of mTOR activation was confirmed in human cystinotic cells 143 .”
Long-Term Outcome of Paediatric Patients with Hereditary Tubular Disorders
Haffner, D., Weinfurth, A., Manz, F., Schmidt, H.-J., Bremer, H. J., Mehls, O., & Scharer, K. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045518 · Cited by 60 · cited 2×
“presumably limits cysteine availability (4) and therefore GSH synthesis, reversing the ratio of GSH to oxidized glutathione”
Ivanova, E. A., Leo, M. G. D., van den Heuvel, L. P., Pastore, A., Dijkman, H. B. P. M., Matteis, M. A. D., & Levtchenko, E. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120998 · Cited by 58 · cited 4×
“Component or interacting partner of the mTOR-complex machinery that informs mTOR kinase on starvation or amino acid abundance. primary PTC cultures from Ctns -knockout mice 122 , and in human cystinotic cells 123 .”
InfluentialDiGiusto, D. L., Stan, R., Krishnan, A. Y., Li, H., Rossi, J. J., & Zaia, J. A. (2013) · Viruses · doi:10.3390/v5112898 · Cited by 58
Ueda, M., O’Brien, K., Rosing, D. R., Ling, A. L., Kleta, R., McAreavey, D., Bernardini, I. M., & Gahl, W. A. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01431005 · Cited by 57 · cited 1×
“Vascular damage 36,37 and hypertension 38,39 have also been described in relation to hyperplasia of renin-producing cells in the juxtaglo-merular apparatus 39 ; chronic kidney disease and disruption of calcium, phosphate and parathyroid hormone homeo stasis; and cystine accumulation in blood…”
Balmer, C., Ballhausen, D., Bosshard, N. U., Steinmann, B. U., Boltshauser, E., Bauersfeld, U., & Superti‐Furga, A. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1678-z · Cited by 56 · cited 1×
“Moreover, isolated autophagy deficits observed in Danon disease, a lysosomal storage disorder caused by mutations in LAMP2 (REFS 150,151) , do not lead to a renal phenotype 150,152 , implying that this defect cannot be the primary reason for the Fanconi syndrome associated with cystinosis.”
Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis
Soliman, N. A., Elmonem, M. A., van den Heuvel, L. P., Hamid, R. H. A., Gamal, M. A., Bongaers, I., Marie, S., & Levtchenko, E. N. (2014) · JIMD Reports · doi:10.1007/8904_2013_288 · Cited by 54 · cited 2×
“Cystinosis is also reported in countries with high levels of consan-guinity such as some countries in the Middle East, but accurate prevalence data are lacking 58,61–64 .”
Accumulation of indigestible substances reduces fusion competence of macrophage lysosomes
Montgomery, R. R., Webster, P., & Mellman, I. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3087 · Cited by 53 · cited 2×
“The combination of these effects should block interlysosomal exchange, and thereby arrest randomization of endocytic load between lysosomes, thus favour their conversion into residual bodies 89,90 .”
Impaired Activity of the γ-Glutamyl Cycle in Nephropathic Cystinosis Fibroblasts
Mannucci, L., Pastore, A., Rizzo, C., Piemonte, F., Rizzoni, G., & Emma, F. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000196370.57200.da · Cited by 53
Antioxidant Effect of Cysteamine in Brain Cortex of Young Rats
Kessler, A., Biasibetti, M., Melo, D. A. D. S., Wajner, M., Dutra‐Filho, C. S., Wyse, Â. T. D. S., & Wannmacher, C. M. D. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9486-7 · Cited by 51 · cited 5×
“Reduced glutathione (GSH) is the major antioxidant in the cystosol, facilitating the neutralization of free radicals such as reactive oxygen species.”
InfluentialCystinosin deficiency causes podocyte damage and loss associated with increased cell motility
Ivanova, E. A., Arcolino, F. O., Elmonem, M. A., Rastaldi, M. P., Giardino, L., Cornelissen, E. A. M., van den Heuvel, L. P., & Levtchenko, E. N. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.013 · Cited by 51 · cited 1×
“Although glomerular proteinuria can be detected early in the disease course (as early as 1 year of age) 30,31 , glomerular filtration rate begins to deteriorate from 5–6 years of age, leading to the development of ERSD.”
Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin
Ruivo, R., Bellenchi, G. C., Chen, X., Zifarelli, G., Sagné, C., Debacker, C., Pusch, M., Supplisson, S., & Gasnier, B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115581109 · Cited by 50 · cited 5×
“The YFPQA sequence comprises part of a ‘PQ-loop’ motif, a defining feature of the PQ-loop family proteins, which are seven transmembrane helices with a duplicated region containing a well-conserved PQ-dipeptide motif 74 .”
InfluentialDevelopment of kidney tubular basement membranes
Abrahamson, D. R., & Leardkamolkarn, V. (1991) · Kidney International · doi:10.1038/ki.1991.50 · Cited by 49 · cited 1×
“The mechanism of HSC-mediated renal repair in vivo has been debated 184,185 , in particular with regard to the route by which HSCs access PTCs across the normally continuous, thick, dense and stiff tubular basement membrane 186,187 .”
The swan-neck lesion: proximal tubular adaptation to oxidative stress in nephropathic cystinosis
Galarreta, C. I., Forbes, M. S., Thornhill, B. A., Antignac, C., Gübler, M.-C., Névo, N., Murphy, M. P., & Chevalier, R. L. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00591.2014 · Cited by 48 · cited 3×
“In Ctns -knockout mice, the increase in oxidative stress preceded the development of swan neck deformities, which could be delayed by administration of mitoquinone, an antioxidant compound that targets mitochondria 104 .”
InfluentialHematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model
Chevronnay, H. P. G., Janssens, V., Smissen, P. V. D., Rocca, C. J., Liao, X.-H., Refetoff, S., Pierreux, C. E., Cherqui, S., & Courtoy, P. J. (2016) · Endocrinology · doi:10.1210/en.2015-1762 · Cited by 48 · cited 1×
“…has been demonstrated in the eyes and thyroid of Ctns -knockout mice, leading to near complete clearance of corneal cystine crystals and preservation of corneal structure 188 , as well as normalization of thyroid-stimulating hormone level and preservation of thyroid follicles, repectively 189 .”
Self-citationChevronnay, H. P. G., Janssens, V., Smissen, P. V. D., Liao, X. H., Abid, Y., Névo, N., Antignac, C., Refetoff, S., Cherqui, S., Pierreux, C. E., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1672 · Cited by 47
Self-citationCystinotic fibroblasts accumulate cystine from intracellular protein degradation.
Thoene, J. G., Oshima, R. G., Ritchie, D. G., & Schneider, J. A. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.10.4505 · Cited by 45 · cited 2×
“According to the estimates provided above, endocytosis of ultrafiltrated disulfide-rich plasma proteins, in particular albumin, is the primary source of lysosomal cystine for PTCs 83,84 .”
Lysosomal Storage Disorders in Egyptian Children
Elmonem, M. A., Mahmoud, I. G. E. D., Mehaney, D. A., Sharaf, S. A. E.-A., Hassan, S., Oraby, A., Salem, F., Girgis, M. Y. F., El-Badawy, A., Abdelwahab, M. S., et al. (2016) · The Indian Journal of Pediatrics · doi:10.1007/s12098-015-2014-x · Cited by 44
Kidney injury, stem cells and regeneration
Humphreys, B. D. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000437332.31418.e0 · Cited by 42 · cited 1×
“The mechanism of HSC-mediated renal repair in vivo has been debated 184,185 , in particular with regard to the route by which HSCs access PTCs across the normally continuous, thick, dense and stiff tubular basement membrane 186,187 .”
Current progress on gene therapy for primary immunodeficiencies
Zhang, L., Thrasher, A. J., & Gaspar, H. B. (2013) · Gene Therapy · doi:10.1038/gt.2013.21 · Cited by 40 · cited 1×
“…infection, β-thalassemia, immunodeficiency diseases such as severe combined or adenosine deaminase immuno-deficiency and metabolic diseases such as adrenoleuko-dystrophy and metachromatic leukodystrophy; no major adverse events have been reported so far, but extreme care remains necessary 191–195 .”
Trauner, D. A., Spilkin, A. M., Williams, J., & Babchuck, L. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.02.062 · Cited by 38
Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation
Rocca, C. J., Kreymerman, A., Ur, S. N., Frizzi, K. E., Naphade, S. B., Lau, A., Tran, T., Calcutt, N. A., Goldberg, J. L., & Cherqui, S. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17107 · Cited by 38 · cited 1×
“…has been demonstrated in the eyes and thyroid of Ctns -knockout mice, leading to near complete clearance of corneal cystine crystals and preservation of corneal structure 188 , as well as normalization of thyroid-stimulating hormone level and preservation of thyroid follicles, repectively 189 .”
Self-citationIdentification and subcellular localization of a new cystinosin isoform
Taranta, A., Petrini, S., Palma, A., Mannucci, L., Wilmer, M. J. G., Luca, V. D., Diomedi‐Camassei, F., Corallini, S., Bellomo, F., van den Heuvel, L. P., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00413.2007 · Cited by 37 · cited 1×
“A longer CTNS isoform can be generated by alternate splicing of exon 12, which removes the GYDQL motif and adds 39 amino acids to produce a 400 amino-acid protein, called cystinosin-LKG 69 (FIG.”
Kidney repair and stem cells: a complex and controversial process
Yeagy, B. A., & Cherqui, S. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1789-x · Cited by 35
Self-citationKalatzis, V., Cherqui, S., Jean, G., Cordier, B., Cochat, P., Broyer, M., & Antignac, C. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102170 · Cited by 34
Self-citationMuscle wasting and adipose tissue browning in infantile nephropathic cystinosis
Cheung, W. W., Cherqui, S., Ding, W. Q., Esparza, M. C., Zhou, P. H., Shao, J., Lieber, R. L., & MAK, R. H. K. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12056 · Cited by 28 · cited 1×
“Tubular lesions that appear in microdissected nephrons as long atrophic tubules (the ‘swan necks’), appending below the glomeruli (the ‘swan heads’). deposition of corneal cystine crystals 16,17 , bone demineralization and deformities 18 , muscle wasting 19 and thyroid dysfunction 20 .”
Self-citationRRAG GTPases link nutrient availability to gene expression, autophagy and lysosomal biogenesis
Martina, J. A., & Puertollano, R. (2013) · Autophagy · doi:10.4161/auto.24371 · Cited by 28
Nephropathic cystinosis associated with cardiomyopathy: A 27-year clinical follow-up
Dixit, M. P., & Greifer, I. (2002) · BMC Nephrology · doi:10.1186/1471-2369-3-8 · Cited by 23
Distribution of cystinosin-LKG in human tissues
Taranta, A., Petrini, S., Citti, A., Boldrini, R., Corallini, S., Bellomo, F., Levtchenko, E. N., & Emma, F. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0958-8 · Cited by 20 · cited 1×
“The cystinosin-LKG isoform represents 5–20% of all CTNS transcripts in most tissues (representing up to 50% of all CTNS transcripts in testes) 71 .”
Common mutation causes cystinosis in the majority of black South African patients
Owen, E. P., Nandhlal, J., Leisegang, F., van der Watt, G., Nourse, P. J., & Gajjar, P. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2980-7 · Cited by 20
Taub, M. L., & Cutuli, F. M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.115 · Cited by 17 · cited 2×
“Importantly, however, genistein has multiple effects, including activation of AMPK 175 , which as mentioned earlier is activated in primary rabbit PTCs with cystinosis knockdown 101 , and inhibition of mTOR signalling 175 , which is already reduced in cystinotic PTCs 157 .”
Thoene, J. G., Goss, T. J., Witcher, M., Mullet, J., N’Kuli, F., Smissen, P. V. D., Courtoy, P. J., & Hahn, S. H. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.01.014 · Cited by 17 · cited 3×
“Cystinosin-containing microvesicles and/or exosomes shed by cystinosin-expressing cells have been suggested as potential vehicles to decrease cystine in cystinotic cells 79,180 .”
Self-citationLysosomal Targeting of Cystinosin Requires AP ‐3
Andrzejewska, Z., Névo, N., Thomas, L., Bailleux, A., Chauvet, V., Benmerah, A., & Antignac, C. (2015) · Traffic · doi:10.1111/tra.12277 · Cited by 11 · cited 1×
“The GYDQL motif interacts with the adaptor protein complex 3 (AP-3), which is responsible for direct lysosomal targeting 72 .”
Towards More Successful Gene Therapy Clinical Trials for β-Thalassemia
Drakopoulou, E., Papanikolaou, E., Georgomanoli, M., & Anagnou, N. P. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990064 · Cited by 9
Ca2+ signalling in human proximal tubular epithelial cells deficient for cystinosin
Ivanova, E. A., Elmonem, M. A., Bongaerts, I., Luyten, T., Missiaen, L., van den Heuvel, L. P., Levtchenko, E. N., & Bultynck, G. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.07.001 · Cited by 8 · cited 1×
“…controls lysosomal dynamics 127 , although no change in the total level of lysosomal calcium store has been detected in cultured cystinotic cells 128 ; and third, through downregulation of Rab–GTPase(s) that normally catalyse lyso somal trafficking, such as Rab27a, which is specifically…”
Metadata
- Authors
- Cherqui, S., & Courtoy, P. J.
- Venue
- Nature Reviews Nephrology
- Published
- 2016-12-19
- Volume
- 13
- Issue
- 2
- Pages
- 115-131
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2565280039
- Cited by
- 201
- References
- 118
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.